Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs
The Medical Letter on Drugs and Therapeutics · 02.03.2026 · 68 (1749) · 40-40
DOI: 10.58347/tml.2026.1749c ↗Kurz gefasst
Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, online erschienen am 02.03.2026.
Themen: Inkontinenz
Abstract (Originalsprache)
Our recent article entitled Lumateperone (Caplyta) for Adjunctive Treatment of Depression1 should have included urinary incontinence among the adverse effects associated with use of second-generation antipsychotic drugs. Urinary incontinence has been reported with both first- and second-generation antipsychotics. Possible causes include the anti-alpha-adrenergic, antidopaminergic, and anticholinergic effects of these drugs, as well as sedation. In an observational study in 200 women 20-40 years old, urinary incontinence was reported by 29% of those taking antipsychotic drugs and by 13% of age-matched controls.
Schlagwörter
Stichwörter der Autor:innen
Zitieren
APA
(2026). Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs. The Medical Letter on Drugs and Therapeutics, 68(1749), 40-40. https://doi.org/10.58347/tml.2026.1749c
Vancouver
Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs. The Medical Letter on Drugs and Therapeutics. 2026;68(1749):40-40. doi:10.58347/tml.2026.1749c
BibTeX
@article{euvimed2026,
title = {Addendum: Urinary Incontinence with Second-Generation Antipsychotic Drugs},
journal = {The Medical Letter on Drugs and Therapeutics},
year = {2026},
volume = {68},
number = {1749},
pages = {40--40},
doi = {10.58347/tml.2026.1749c}
}
EUVIMED